Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Jullien

Showing results (71-80 of 126) with videos related to

Pageof 13
Sort By:
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 8, 2008
Quantification of seven nucleoside/nucleotide reverse transcriptase inhibitors in human plasma by high-performance liquid chromatography with tandem mass-spectrometryThomas Le Saux, Stéphanie Chhun, Elisabeth Rey, et al.
The Pediatric Infectious Disease Journal|August 31, 2006
Change to a once-daily combination including boosted atazanavir in HIV-1-infected childrenEugenia Macassa, Constance Delaugerre, Jean Paul Teglas, et al.
Journal of Clinical Pharmacology|September 8, 2018
Proposition of a Minimal Effective Dose of Vigabatrin for the Treatment of Infantile Spasms Using Pediatric and Adult Pharmacokinetic DataMarwa Ounissi, Christelle Rodrigues, Hugues Bienayme, et al.
British Journal of Clinical Pharmacology|September 26, 2007
Pharmacokinetic modelling of the placental transfer of nelfinavir and its M8 metabolite: a population study using 75 maternal-cord plasma samplesDéborah Hirt, Saïk Urien, Vincent Jullien, et al.
Antimicrobial Agents and Chemotherapy|May 26, 2006
Pregnancy-related effects on nelfinavir-M8 pharmacokinetics: a population study with 133 womenDéborah Hirt, Jean-Marc Treluyer, Vincent Jullien, et al.
Infectious Diseases and Therapy|June 3, 2026
Micafungin Sequestration and Late Release During Continuous Renal Replacement Therapy with Polyacrylonitrile- and Polysulfone-Derived FiltersJulien Massol, Valentin Maulet, Vincent Jullien, et al.
Antibiotics (Basel, Switzerland)|November 11, 2022
Population Pharmacokinetics of Orally Administered Clindamycin to Treat Prosthetic Joint Infections: A Prospective StudyLéo Mimram, Sophie Magréault, Younes Kerroumi, et al.
Antimicrobial Agents and Chemotherapy|October 27, 2004
Maternal-fetal transfer and amniotic fluid accumulation of nucleoside analogue reverse transcriptase inhibitors in human immunodeficiency virus-infected pregnant womenHélène Chappuy, Jean-Marc Tréluyer, Vincent Jullien, et al.
Malaria Journal|December 18, 2014
Fixed dose artesunate amodiaquine - a phase IIb, randomized comparative trial with non-fixed artesunate amodiaquineBernhards Ogutu, Elizabeth Juma, Charles Obonyo, et al.
The Journal of Antimicrobial Chemotherapy|October 26, 2023
What clindamycin dose should be administered by continuous infusion during combination therapy with rifampicin? A prospective population pharmacokinetics studyLéo Mimram, Sophie Magréault, Younes Kerroumi, et al.
Pageof 13

Showing results (71-80 of 126) with videos related to

Sort By:
Pageof 13
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 8, 2008
Quantification of seven nucleoside/nucleotide reverse transcriptase inhibitors in human plasma by high-performance liquid chromatography with tandem mass-spectrometryThomas Le Saux, Stéphanie Chhun, Elisabeth Rey, et al.
The Pediatric Infectious Disease Journal|August 31, 2006
Change to a once-daily combination including boosted atazanavir in HIV-1-infected childrenEugenia Macassa, Constance Delaugerre, Jean Paul Teglas, et al.
Journal of Clinical Pharmacology|September 8, 2018
Proposition of a Minimal Effective Dose of Vigabatrin for the Treatment of Infantile Spasms Using Pediatric and Adult Pharmacokinetic DataMarwa Ounissi, Christelle Rodrigues, Hugues Bienayme, et al.
British Journal of Clinical Pharmacology|September 26, 2007
Pharmacokinetic modelling of the placental transfer of nelfinavir and its M8 metabolite: a population study using 75 maternal-cord plasma samplesDéborah Hirt, Saïk Urien, Vincent Jullien, et al.
Antimicrobial Agents and Chemotherapy|May 26, 2006
Pregnancy-related effects on nelfinavir-M8 pharmacokinetics: a population study with 133 womenDéborah Hirt, Jean-Marc Treluyer, Vincent Jullien, et al.
Infectious Diseases and Therapy|June 3, 2026
Micafungin Sequestration and Late Release During Continuous Renal Replacement Therapy with Polyacrylonitrile- and Polysulfone-Derived FiltersJulien Massol, Valentin Maulet, Vincent Jullien, et al.
Antibiotics (Basel, Switzerland)|November 11, 2022
Population Pharmacokinetics of Orally Administered Clindamycin to Treat Prosthetic Joint Infections: A Prospective StudyLéo Mimram, Sophie Magréault, Younes Kerroumi, et al.
Antimicrobial Agents and Chemotherapy|October 27, 2004
Maternal-fetal transfer and amniotic fluid accumulation of nucleoside analogue reverse transcriptase inhibitors in human immunodeficiency virus-infected pregnant womenHélène Chappuy, Jean-Marc Tréluyer, Vincent Jullien, et al.
Malaria Journal|December 18, 2014
Fixed dose artesunate amodiaquine - a phase IIb, randomized comparative trial with non-fixed artesunate amodiaquineBernhards Ogutu, Elizabeth Juma, Charles Obonyo, et al.
The Journal of Antimicrobial Chemotherapy|October 26, 2023
What clindamycin dose should be administered by continuous infusion during combination therapy with rifampicin? A prospective population pharmacokinetics studyLéo Mimram, Sophie Magréault, Younes Kerroumi, et al.
Pageof 13